Showing results (1081-1090 of 1,139) with videos related to
Sort By:
Pageof 114
Trials|May 27, 2006
Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]Mohammad Imran Khan, Rion Leon Ochiai, Hasan Bin Hamza, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 2, 2015
A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in SingaporeBoon Yew Tan, Rita Yu Yin Yong, Hector Barajas-Martinez, et al.Immunity|July 17, 2012
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cellsMuzlifah Haniffa, Amanda Shin, Venetia Bigley, et al.Archives of Physical Medicine and Rehabilitation|April 12, 2017
Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized TrialJanna L Friedly, Bryan A Comstock, Judith A Turner, et al.BMJ Health & Care Informatics|September 22, 2025
Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reportsAndres Tamm, Helen J S Jones, Neel Doshi, et al.The Lancet. Oncology|September 30, 2021
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 studyJuan W Valle, Arndt Vogel, Crystal S Denlinger, et al.The Lancet. Oncology|March 30, 2019
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyJohn N Primrose, Richard P Fox, Daniel H Palmer, et al.Future Oncology (London, England)|August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancerJames J Harding, Jia Fan, Do-Youn Oh, et al.BMJ Health & Care Informatics|June 23, 2022
Establishing a colorectal cancer research database from routinely collected health data: the process and potential from a pilot studyAndres Tamm, Helen Js Jones, William Perry, et al.Pain|December 30, 2025
A double-blind, placebo-controlled, multi-crossover trial of treatment with a chemokine antagonist for knee osteoarthritis painRobert R Edwards, Thaddeus Tarpey, Michael Ashburn, et al.Pageof 114